← Evidence map

ReviewDrugs2021

Entrectinib: A Review in NTRK+ Solid Tumours and ROS1+ NSCLC.

James E FramptonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33871816